Siga Technologies (United States)
SIGA Technologies, Inc. is an American pharmaceutical company founded in 1995, based in New York City, which develops and sells pharmaceutical solutions for the antiviral treatment of smallpox, monkeypox, cowpox, and vaccinia complications. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Siga Technologies (United States), United States, covering academic research published from 2000 to 2024. Read More.
Open Access Percentage
67%
Total
Publications
128
Total Open
Publications
86
Total
Citations
6.3K
Open Access
Percentage
67%
Total
Publications
128
Total Open
Publications
86
Total
Citations
6.3K
Breakdown
Publisher Open
2%
Both
30%
Other Platform Open
35%
Closed
33%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 39%
16
Hybrid 17%
7
No Guarantees 44%
18
Other Platform Open
Domain 98%
81
Public 6%
5
Other Internet 5%
4
Preprint 4%
3
Institution 2%
2
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 82 |
Europe PMC | Domain | 60 |
Semantic Scholar | Public | 5 |
Le Centre pour la Communication Scientifique Directe - HAL - Institut Pasteur | Institution | 3 |
CiteSeer X | Other Internet | 2 |
Cardiff University - ORCA Online Research @Cardiff | Institution | 2 |
bioRxiv | Preprint | 2 |
DOI | Other Internet | 1 |
California Digital Library - eScholarship | Other Internet | 1 |
arXiv | Preprint | 1 |